Active specific immunotherapy for stage II and stage III human colon cancer: a randomised trialJan B. Vermorken, Herbert M. Pinedo, Renate Ezinga et al.|The Lancet|1999Cited by 503
Combined immunotherapy with granulocyte-macrophage colony-stimulating factor-transduced allogeneic prostate cancer cells and ipilimumab in patients with metastatic castration-resistant prostate cancer: a phase 1 dose-escalation trialAlfons JM van den Eertwegh, Winald R. Gerritsen, Jurjen Versluis et al.|The Lancet Oncology|2012Cited by 357